Pembrolizumab
CCR 4268
Phase 1 other terminated
Quick answer
Pembrolizumab for Cervix Cancer is a Phase 1 program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Cervix Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- terminated